Hospital
Piggott Community Hospital
Piggott Community Hospital was paid $2.94M by Medicaid between Jan 2018 and Nov 2024, across 68 billing codes. Its largest line is 90853, Group psychotherapy (other than of a multiple-family group) — 29% of everything it billed.
33Billing provider infoPIGGOTT COMMUNITY HOSPITAL
PIGGOTT, AR 72454
PIGGOTT, AR 72454
33aNPI1891781837assigned 09/26/2005
33bProvider typeCritical Access Hospital
28Total paid$2.94M
24GClaims116,768
24DCodes billed68
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#4 of 34
Median peer was paid$773K
This provider vs. median3.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,872 | $242K | |
| 2019 | 16,060 | $436K | |
| 2020 | 13,680 | $259K | |
| 2021 | 16,415 | $270K | |
| 2022 | 19,935 | $574K | |
| 2023 | 22,324 | $654K | |
| 2024incomplete | 17,482 | $499K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90853 | Group psychotherapy (other than of a multiple-family group) | 29% | 7,706 | 778 | $856K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 4,074 | 3,202 | $334K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 5,097 | 3,806 | $299K |
| 80053 | Comprehensive metabolic panel | 7.8% | 16,959 | 12,024 | $230K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.5% | 15,393 | 10,355 | $131K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 4.0% | 3,397 | 2,705 | $118K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.1% | 6,915 | 4,608 | $91K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.5% | 798 | 595 | $74K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 1,593 | 323 | $72K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 4,678 | 4,022 | $60K |
| 71045 | Radiologic examination, chest; single view | 1.8% | 4,025 | 2,770 | $54K |
| X4011 | State-specific procedure code | 1.7% | 337 | 296 | $51K |
56 more codes
| A0425 | Ground mileage, per statute mile | 1.7% | 987 | $50K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 459 | $47K |
| 85027 | 1.6% | 5,706 | $46K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 3,866 | $38K |
| 80061 | Lipid panel | 1.3% | 3,775 | $38K |
| 83880 | 1.2% | 2,073 | $37K | |
| 80050 | General health panel | 1.2% | 928 | $36K |
| 84484 | 1.0% | 3,940 | $30K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 336 | $20K |
| 81001 | <1% | 4,754 | $19K | |
| Y7506 | <1% | 856 | $18K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 693 | $17K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 913 | $14K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 122 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,553 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 777 | $12K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,003 | $10K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 608 | $9K |
| G0378 | Hospital observation service, per hour | <1% | 63 | $8K |
| 87088 | <1% | 1,296 | $8K | |
| X4006 | <1% | 27 | $8K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 174 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,517 | $7K |
| J3490 | Unclassified drugs | <1% | 417 | $7K |
| 87040 | <1% | 1,174 | $6K | |
| 86140 | <1% | 1,011 | $5K | |
| 82553 | <1% | 244 | $5K | |
| 87807 | <1% | 456 | $4K | |
| 83605 | <1% | 503 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 816 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 58 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 141 | $3K |
| 83690 | <1% | 372 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 61 | $2K |
| 84146 | <1% | 146 | $2K | |
| 81000 | <1% | 675 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 17 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 90 | $2K |
| 85610 | <1% | 627 | $2K | |
| 81003 | <1% | 395 | $707.32 | |
| 84703 | <1% | 68 | $697.25 | |
| 80306 | <1% | 52 | $617.64 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 418 | $507.54 |
| 85379 | <1% | 76 | $502.85 | |
| 82962 | <1% | 50 | $397.45 | |
| 83735 | <1% | 146 | $380.62 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 15 | $375.04 |
| 73630 | <1% | 16 | $283.23 | |
| 90688 | <1% | 22 | $274.55 | |
| 83655 | <1% | 12 | $178.76 | |
| 82150 | <1% | 18 | $169.39 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 42 | $153.42 |
| 85730 | <1% | 58 | $114.97 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 129 | $4.38 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 27 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAGEE, JAMES (EXEC DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Piggott Community Hospital | Campbell, MO | $1.08M |
| Piggott Community Hospital | Piggott, AR | $221K |
| Piggott Community Hospital | Rector, AR | $165K |
| Piggott Community Hospital | Piggott, AR | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.